Seelos Therapeutics Announces Acquisition of an Exclusive Worldwide License of Gene Therapy Program to Address Parkinson's Disease from Duke University
Duke Health has announced three pilot funding opportunities to build infastructure and pilot data in support of an upcoming institutional application to become an Alzheimer's Disease Center.
Chi and Hsu found that depriving tumors of cysteine, a non-essential amino acid that becomes essential only to tumor cells once they have been malignantly transformed, has been shown to shrink tumor cells.
The Center for Genomic and Computational Biology (GCB) received a grant from the National Science Foundation (NSF) to create an International Research Experiences for Students (IRES) program called “Dissecting the Regulatory Genome Duke-Berlin Training Program.”